This is consistent with the well-established association of ErbB receptors, including ErbB3, with metastatic processes as well as with cytokine/pro-inflammatory pathways that play important roles in breast cancer progression [22, 36, 37]. The gene discussed is ERBB3; the disease is breast carcinoma.